Antioxidant response and oxidative damage in brain cortex after high dose of pilocarpine.
Pilocarpine is a cholinergic agonist capable to induce seizures and an epilepticus-like state in rodents. This status epilepticus (SE) is an useful animal model to study the development and understanding of the neuropathology, behavioural and electroencephalographic alterations of human temporal lobe epilepsy. It has been suggested a relationship between SE and reactive oxygen species (ROS) that can result in seizure-induced neurodegeneration. The aim of this study was to evaluate the existence of oxidative damage and the changes in the antioxidant system in cortex after administration of a high pilocarpine dose. Rats were injected with pilocarpine (350 mg/kg i.p.) or with saline as control and 2h after the animals were sacrificed. Malondialdehyde (MDA) levels, as marker of lipid peroxidation, significantly increased (64%) after pilocarpine treatment evidencing oxidative damage. Antioxidant enzyme activities--catalase (CAT), glutathione peroxidase (GP) and superoxide dismutase (SOD)--significantly increased in response to pilocarpine (28%, 28% and 21%, respectively). GP and Mn-SOD gene expression were induced by pilocarpine treatment. Vitamin E concentration in brain cortex decreased (15%) as result of pilocarpine administration. In conclusion, the high dose of pilocarpine, used in the present study, induces oxidative damage and increases antioxidant enzyme activities and expression in brain cortex. Moreover, increased lipid peroxidation produces the consumption of Vitamin E.
Tejada
S
S
Laboratori de Neurofisiologia, Departament de Biologia Fonamental i Ciències de la Salut, Universitat de les Illes Balears, Crta. Valldemossa, Km 7.5, E-07122 Palma de Mallorca, Balears, Spain.
Sureda
A
A
Roca
C
C
Gamundí
A
A
Esteban
S
S
D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects* / Q000201:enzymology; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D018721:Muscarinic Agonists / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects*; D010862:Pilocarpine / Q000494:pharmacology*; D012313:RNA / Q000096:biosynthesis / Q000302:isolation & purification; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014810:Vitamin E / Q000378:metabolism
D000975:Antioxidants; D018721:Muscarinic Agonists; D017382:Reactive Oxygen Species; D010862:Pilocarpine; D014810:Vitamin E; D008315:Malondialdehyde; D012313:RNA